Postprandial Response to Almond Consumption in Overweight Hispanic Pregnant Women
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01919476|
Recruitment Status : Completed
First Posted : August 9, 2013
Last Update Posted : August 8, 2016
|Condition or disease||Intervention/treatment||Phase|
|Diabetes, Gestational||Other: Bagel Other: Cream Cheese Other: Almond Butter||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||18 participants|
|Intervention Model:||Crossover Assignment|
|Official Title:||Postprandial Response to Almond Consumption in Overweight Hispanic Pregnant Women|
|Study Start Date :||September 2011|
|Actual Primary Completion Date :||March 2016|
|Actual Study Completion Date :||March 2016|
Active Comparator: Control Meal: Bagel, cream cheese
Control meal consists of bagel with cream cheese and apple juice.
Other: Cream Cheese
Experimental: Almond Meal: Bagel, almond butter
Almond meal consists of bagel with almond butter and apple juice.
Other: Almond Butter
- Change in markers for glucose intolerance. [ Time Frame: 0, .5, 1, 2, 3, 4, 5 hours following a meal ]After consuming the breakfast meal markers for glucose intolerance will be measured at the time points listed
- Change in metabolic markers [ Time Frame: 0, .5, 1, 2, 3, 4, 5 hours following a meal ]After consuming the breakfast meal metabolic markers will be measured at the time points listed.
- Change in satiety markers [ Time Frame: 0, .5, 1, 2, 3, 4, 5 hours following a meal ]After consuming the breakfast meal satiety markers will be measured at the time points listed. Satiety questionnaires will also be given at the listed time points and food intake from a buffet will be measured.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01919476
|United States, California|
|Children's Hospital Oakland Research Institute|
|Oakland, California, United States, 94609|
|Principal Investigator:||Janet C King, PhD||Children's Hospital & Research Institute Oakland|